Thrombospondins: from structure to therapeutics
Top Cited Papers
- 12 January 2008
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 65 (5), 700-712
- https://doi.org/10.1007/s00018-007-7486-z
Abstract
The thrombospondins (TSPs) are a family of five proteins that are involved in the tissue remodeling that is associated with embryonic development, wound healing, synaptogenesis, and neoplasia. These proteins mediate the interaction of normal and neoplastic cells with the extracellular matrix and surrounding tissue. In the tumor microenvironment, TSP-1 has been shown to suppress tumor growth by inhibiting angiogenesis and by activating transforming growth factor β. TSP-1 inhibits angiogenesis through direct effects on endothelial cell migration and survival, and through effects on vascular endothelial cell growth factor bioavailability. In addition, TSP-1 may affect tumor cell function through interaction with cell surface receptors and regulation of extracellular proteases. Whereas the role of TSP-1 in the tumor microenvironment is the best characterized, the other TSPs may have similar functions. (Part of a Multi-author Review)Keywords
This publication has 99 references indexed in Scilit:
- Thrombospondin‐1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor‐related protein‐1 (LRP‐1)Journal of Cellular Physiology, 2006
- Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switchProceedings of the National Academy of Sciences, 2006
- Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic SwitchCell Cycle, 2006
- A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic PhenotypeJNCI Journal of the National Cancer Institute, 2006
- Differentiation of tumours of ductal and lobular origin: II. Proteomics of invasive ductal and lobular breast carcinomasBiomedical Papers, 2005
- Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancersEuropean Journal Of Cancer, 2004
- RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesisCancer Cell, 2003
- The Hallmarks of CancerCell, 2000
- Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic modelsEuropean Journal Of Cancer, 1996
- Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptorSurgery, 1996